Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences - Basic and Translational Neurosciences

[11C]UCB-J PET white matter ROI optimization for Parkinson’s Disease imaging of synaptic density

Nikkita Khattar, David Matuskey, Sule Tinaz, Richard Carson and Takuya Toyonaga
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P1258;
Nikkita Khattar
1Yale University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Matuskey
1Yale University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sule Tinaz
2Yale School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Carson
1Yale University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takuya Toyonaga
1Yale University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

P1258

Introduction: [11C]UCB-J, a radioligand for synaptic vesicle glycoprotein 2A (SV2A), is a potential in vivo biomarker for synaptic density (1, 2). [11C]UCB-J can be used to investigate changes in synaptic density in several neurological diseases, including Parkinson’s disease (PD) (3). PD is characterized by depletion of central and peripheral dopamine, a neurotransmitter generated in the substantia nigra (SN), leading to progressively worsening difficulties with movement, balance, and cognition (4). To fully evaluate the specific binding of [11C]UCB-J in the SN, a reference region with low specific binding and with minimal noise is needed. The centrum semiovale (CS) has been used as a reference region, but its relatively high noise due to its small size is detrimental. In this study, we generated, optimized, and evaluated new white matter (WM) regions of interest (ROIs) derived from individual MR T1-weighted images (T1Wis) for more reliable synaptic density measurements in the SN of healthy controls (HC) and PD subjects.

Methods: Nine HCs (age: 59.2±7.8 y, M:F = 3:6) and seven PD subjects (age: 60.6±10.5 y, M:F=2:5) participated in this study. All subjects underwent at least 60 min 11C-UCB-J PET acquisition with arterial blood sampling and metabolite assay. The volume of distribution (VT) was estimated by one-tissue compartment modeling. The ROIs of SN and CS were defined in the automated anatomic labeling (AAL) space. Those ROIs were applied to the individual VT images by using non-linear transformation from AAL space to individual T1WIs and linear transformation from individual T1WIs to individual PET image space. The individual T1WIs were segmented by FreeSurfer (FS) 6.0 and cerebral WM ROI was smoothed and thresholded to generate a sequence of FSWM ROIs ranging in size from 0.5 to 200 mL (Fig A). The distribution volume ratio (DVR) within the SN was calculated using CS or FSWM ROIs of different sizes as a reference region. Partial volume correction was applied to the VT in CS and FSWM ROIs using iterative Yang algorithm with FS segmentation. The DVRs in SN were compared between HC and PD groups using a t-test without correction for multiple comparisons.

Results: Fig B shows the VT per CS and FSWM volumes for both groups. The percent differences of VT in CS and each FSWM ROI between groups ranged from 2.4 – 6.9%, with increasing difference with increasing ROI size. This indicates that due to their size, larger FSWM ROIs capture increasing spillover from the specific binding in gray matter regions that could be different between PD and HC subject groups (3). Note that there was no statistically significant group differences in VT for CS or other sizes of FSWM ROIs.

Fig C shows the mean DVR in the SN for both groups using the CS and each FSWM ROI as the reference region. The DVR in the SN was significantly different between HC and PD groups (p<0.05) using each reference region, with the 8 mL reference region exhibiting the highest percent differences (27.4%) with the highest effect size (Cohen’s d =2.80).

Conclusions: Compared to the CS, VT using the 8 mL FSWM ROI showed the lowest difference in PD vs HC groups. Moreover, compared to CS-derived results, the SN DVR calculated using the 8 mL FSWM ROI as a reference region exhibited lower variability, as well as the largest and most significant difference between the PD and HC groups. Taken together, these results suggest that the 8 mL FSWM ROI may be an optimal reference region for studying synaptic density changes in PD and other neurodegenerative diseases using [11C]UCB-J.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
[11C]UCB-J PET white matter ROI optimization for Parkinson’s Disease imaging of synaptic density
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
[11C]UCB-J PET white matter ROI optimization for Parkinson’s Disease imaging of synaptic density
Nikkita Khattar, David Matuskey, Sule Tinaz, Richard Carson, Takuya Toyonaga
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P1258;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
[11C]UCB-J PET white matter ROI optimization for Parkinson’s Disease imaging of synaptic density
Nikkita Khattar, David Matuskey, Sule Tinaz, Richard Carson, Takuya Toyonaga
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P1258;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Early detection and tracking of activated macrophages and microglia in a mouse model of multiple sclerosis using [18F]OP-801 PET imaging before and after a novel immunomodulatory drug
  • Investigating Neuromodulatory Effects of rTMS and Their Stimulation Parameter Dependence in the NHP Model
  • Tributyrin Supplementation Increases Brain Butyrate Availability and Improves Parkinson’s Disease Motor Symptoms
Show more Neurosciences - Basic and Translational Neurosciences

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire